ADMA Biologics, Inc. (ADMA)

ADMA Biologics Revenue

ADMA Biologics had revenue of $283.18M in the twelve months ending March 31, 2024, with 55.68% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $81.88M with 43.86% year-over-year growth. In the year 2023, ADMA Biologics had annual revenue of $258.22M with 67.59% growth.

• Revenue (ttm): $283.18M
• Revenue Growth: +55.68%
• P/S Ratio: 8.55
• Revenue / Employee: $453,808
• Employees: 624
• Market Cap: 2.50B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	258.22M	104.14M	67.59%
Dec 31, 2022	154.08M	73.14M	90.36%
Dec 31, 2021	80.94M	38.72M	91.72%
Dec 31, 2020	42.22M	12.87M	43.85%
Dec 31, 2019	29.35M	12.36M	72.79%
Dec 31, 2018	16.99M	-5.78M	-25.37%
Dec 31, 2017	22.76M	12.10M	113.49%
Dec 31, 2016	10.66M	3.48M	48.53%
Dec 31, 2015	7.18M	1.26M	21.34%
Dec 31, 2014	5.92M	2.85M	92.84%
Dec 31, 2013	3.07M	1.95M	174.35%
Dec 31, 2012	1.12M	357.08K	46.92%
Dec 31, 2011	761.04K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.